Hummingbird Bioscience Doses First Patient in Phase II Cancer Trial

This clinical trial advance could lead to new treatment options for advanced squamous cell cancers.

Auto-scored: Medical trial announcement with no apparent risk; it’s a real but partial step in drug development.